MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers
Sign Up to like & getrecommendations! Published in 2022 at "Heart Failure Reviews"
DOI: 10.1007/s10741-022-10231-z
Abstract: Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy and is characterized by increased left ventricular wall thickness, but existing diagnostic and treatment approaches face limitations. MicroRNAs (miRNAs) are type of noncoding RNA molecule that… read more here.
Keywords: hypertrophic cardiomyopathy; cardiomyopathy pathogenesis; treatment; pathogenesis diagnosis ... See more keywords
MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
Sign Up to like & getrecommendations! Published in 2021 at "Diagnostics"
DOI: 10.3390/diagnostics11091720
Abstract: MicroRNAs (miRNAs) are a class of non-coding RNAs of about 20 nucleotides in length, involved in the regulation of many biochemical pathways in the human body. The level of miRNAs in tissues and circulation can… read more here.
Keywords: arrhythmogenic dilated; micrornas hypertrophic; dilated cardiomyopathy; hypertrophic arrhythmogenic ... See more keywords